S&P 500
7,464.00
+0.15%
Dow Jones
52,389.60
+0.18%
Nasdaq 100
29,901.60
+0.34%
Russell 2000
3,015.57
+0.21%
FTSE 100
10,621.80
+0.77%
Nikkei 225
70,084.80
-0.81%

Health and Healthcare

OncoGenex Prices Secondary Offering, Shares Fall (OGXI)

Photo of Paul Ausick
By Paul Ausick Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Invalid Image
Cancer therapy developer OncoGenex Pharmaceuticals Inc. (NASDAQ: OGXI) has priced a secondary offering of 4.165 million common shares at $12.00/share, a discount of 31% to yesterday’s closing price of $17.43. Needless to say the shares are getting pounded today.

OncoGenex expects to realize about $46.8 million from the offering, net of fees and expenses. Leerink Swann LLC and Stifel Nicolaus Weisel are acting as joint book-running managers and Lazard Capital Markets LLC and William Blair & Company, L.L.C. are acting as co-managers. The underwriters have a 30-day over-allotment option of 624,750 shares.

The company did not specify how it plans to use the proceeds from the sale.

Shares are down nearly -20% at $13.99 in a 52-week range of $8.63-$18.99.

Contact [email protected] for any questions or corrections.

*$149 for two years (or $1.43 per week) is an introductory promotion for new members only. 62% discount based on the current list price of Stock Advisor of $199/year. Membership will renew at the then-current list price at the end of the membership term.

Stock Advisor returns are 930% as compared to the S&P 500 returns of 185% as of April 7, 2026.

Follow 24/7 Wall St. on Google
Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

The Celebration Portfolio That Pays For Date Nights, Birthdays, And Anniversaries Forever
Drew Wood |

The Celebration Portfolio That Pays For Date Nights, Birthdays, And Anniversaries Forever
Forced to Take an RMD in a Down Market? Here's the Tax Move That Avoids Selling Low
Gerelyn Terzo |

Forced to Take an RMD in a Down Market? Here's the Tax Move That Avoids Selling Low

Continue Reading

Jon C. Ogg |

Top Active Trader Alert Stocks (ABK, AAPL, ARMH, CTIC, CWTR, INFN, MSFT, OGXI)

Active traders and day traders have many stocks to choose from this Wednesday morning.  We are tracking news and moves…

6 Biotechs Seriously on the Move
Chris Lange |

6 Biotechs Seriously on the Move

A few biotech companies made fantastic runs in Thursday’s session. We have included information about each company, as well as…

Paul Ausick |

Busiest IPO Week of the Year: 14 Companies on the Calendar

ThinkstockFour of last week’s six initial public offering (IPO) candidates successfully launched into the public equity markets, but the reception…

4 Biotech IPOs Hoping to Become First U.S. IPO of 2016
Paul Ausick |

4 Biotech IPOs Hoping to Become First U.S. IPO of 2016

To say that the month of January was a bust for initial public offerings (IPOs) is an understatement. January was…

Week of November 9 Sees 9 IPOs on the Calendar
Paul Ausick |

Week of November 9 Sees 9 IPOs on the Calendar

Two holdovers and seven new entries are on the coming week's IPO calendar, including four biotechs and two financial companies.

Paul Ausick |

Health Care Dominates IPO Schedule for First Week of February

Including one holdover from last week, there are 12 IPOs on the calendar for the first week of February.

Paul Ausick |

8 IPOs on the Calendar for Week of July 13

The initial public offering (IPO) calendar heats up again in the week of July 13, with eight offerings scheduled to…

3 New Biotech IPOs on Calendar for Next Week
Paul Ausick |

3 New Biotech IPOs on Calendar for Next Week

Blank-check company KLR Energy Acquisition Corp. (NASDAQ: KLREU) completed its initial public offering (IPO) last Friday, the first successful IPO…

Paul Ausick |

8 IPOs Coming Next Week

This week’s calendar includes eight companies seeking about $1.2 billion in financing from the public markets.

Top Gaining Stocks

Corning
GLW • Vol: 24,307,400
KLA
KLAC • Vol: 14,628,648
Western Digital
WDC • Vol: 11,268,872
Applied Materials
AMAT • Vol: 14,164,881
Axon Enterprise
AXON • Vol: 1,847,989

Top Losing Stocks

Honeywell
HON • Vol: 7,773,157
Coterra Energy
CTRA • Vol: 73,319,495
Super Micro Computer
SMCI • Vol: 91,227,161
Copart
CPRT • Vol: 18,101,097
Ulta Beauty
ULTA • Vol: 895,681